ATS ATS Corp /ATS

MIXED Impact: 6/10 6-K
Horizon weeks Filed May 28, 2026 Processed 17d 21h ago SEC 0001394832-26-000017
Notable filing: 6-K
Latest settled — T+5d
ATS ▼ -5.19% at T+5d
NEUTRAL call ✗ call lost -5.19% · α vs SPY -5.14% · entry $30.43 → $28.85
Next anchor: T+20d in 11d
Last close $27.37 (close Jun 12) · -10.06% from $30.43 entry
Entry anchored
May 27, 03:59 PM ET
via Databento tick
T+1d
+1.61%
call +1.61% · α +1.37%
$30.92
settled 17d ago
T+5d
-5.19%
call -5.19% · α -5.14%
$28.85
settled 11d ago
T+20d
call — · α —
in 11d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

ATS reported Q4 FY2026 results with adjusted revenues of $744.3M (+3.2% YoY) and adjusted EBITDA of $102.5M (+5.6% YoY), but adjusted EPS declined 12.2% to $0.36. The company is executing a major restructuring of its transportation business, incurring $28.3M in reorganization costs and closing facilities, while guiding for modest FY2027 revenue growth and 50-75bps margin expansion. Order bookings fell 18.4% YoY to $704M and backlog declined 8.5% to $1.958B, signaling demand headwinds.

Actionable Insight

ATS is undergoing a significant portfolio transformation, exiting transportation and restructuring operations, which creates near-term earnings noise but targets 50-75bps margin expansion in FY2027. The 18.4% bookings decline and 8.5% backlog contraction signal demand softness, particularly in life sciences, that may pressure revenue visibility. Watch Q1 FY2027 revenue guidance of $700M-$740M and monitor whether margin improvement materializes as restructuring costs phase down.

Key Facts

  • Q4 adjusted revenues $744.3M, +3.2% YoY; organic revenue growth was only 1.5%
  • Q4 adjusted EPS $0.36, -12.2% YoY from $0.41
  • Q4 adjusted EBITDA $102.5M, +5.6% YoY; adjusted EBITDA margin improved 31bps to 13.8%
  • Q4 net loss of $16.2M improved from -$68.9M a year ago, driven by $146.9M prior-year EV customer settlement
  • Order bookings $704M, -18.4% YoY; organic bookings declined 19.3%
  • Order backlog $1,958M, -8.5% YoY; life sciences backlog down 10.2% to $1,077M
  • Transportation revenues collapsed 61.1% YoY to $26.6M; segment being restructured and will cease to be reported separately
  • Restructuring charges of $15.2M in Q4; $28.3M in transportation reorganization costs; $9.8M in services reorganization costs
  • Net debt reduced to $1,151.2M from $1,474.5M; leverage ratio improved to 2.8x from 3.9x
  • Free cash flow of $124.1M in Q4, up from $10.3M a year ago
  • FY2027 guidance: Q1 revenues $700M-$740M; modest full-year revenue growth; adjusted operating margin expected to improve 50-75bps
  • Transportation reorganization expected to remove ~$50M in dilutive revenues in FY2027

Financial Impact

Q4 adjusted revenues $744.3M (+3.2% YoY), adjusted EPS $0.36 (-12.2% YoY), adjusted EBITDA $102.5M (+5.6% YoY). FY2026 full-year adjusted revenues $2,970.1M (+10.8% YoY), adjusted EPS $1.69 (+15.0% YoY).

revenueepsebitdaorder_bookingsorder_backlogdebt

Risk Factors

  • Order bookings declining 18.4% YoY with organic bookings down 19.3% signals weakening demand pipeline
  • Life sciences revenue fell 9.3% YoY and backlog dropped 10.2%, the company's largest end market
  • Transportation restructuring carries execution risk; $28.3M in reorganization costs already booked with more expected
  • Tariff exposure: ~20% of adjusted revenues from Canadian/European operations sold into the U.S. face potential tariff impacts
  • Adjusted EPS declining 12.2% YoY despite revenue growth indicates margin pressure from restructuring costs

Market Snapshot

Exchange
NYSE
Sector
General Industrial Machinery & Equipment, NEC
Analyst Consensus
82% bullish (11 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001394832-26-000017
Document: form6k-fy26q4.htm0001394832-26-000017
Document: 0001394832-26-000017-index-headers.html0001394832-26-000017
Document: 0001394832-26-000017-index.html0001394832-26-000017
Document: 0001394832-26-000017.txt0001394832-26-000017
4 reports for ATS
Performance horizon
Filters
Rows
Reports for ATS — sortable, filterable
Type Now
Jun 11, 2026
3d ago
6-K
NEUTRAL ★ 2/10
$26.70 awaiting T+5awaiting T+5$27.37 (+2.51%)
Jun 11, 2026
3d ago
Institutional Cluster
MIXED ★ 5/10
$26.42 awaiting T+5awaiting T+5$27.37 (+3.60%)
May 28, 2026
17d ago
6-K
MIXED ★ 6/10
$30.43 $28.85▼ −5.19%▼ −5.14%$27.37 (−10.06%)
May 18, 2026
27d ago
6-K
NEUTRAL ★ 2/10
$31.95 $34.70▲ +8.61%▲ +6.99%$27.37 (−14.33%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 2h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access